HeartSciences Quote - HSCS

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.45

Bid

3.45

Ask

3.82

Volume

9,893

3.4153 Day's Range 3.57

2.36 52 Week Range 18.50

Market Cap

3.382M

Previous Close

3.47

Open

3.46

Last Trade

3.45

Last Trade Time

15:15:09

Financial Volume

US$ 34,275

VWAP

3.4646

Average Volume (3m)

36,971

Shares Outstanding

980,321

Dividend Yield

PE Ratio

-0.51

Earnings Per Share (EPS)

-6.74

Revenue

19k

Net Profit

-6.61M

Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-o... Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. Show more

Sector

Ortho,prosth,surg Appl,suply

Industry

Ortho,prosth,surg Appl,suply

Website

www.heartsciences.com

Headquarters

Southlake, Texas, USA

Founded

HeartSciences Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker HSCS. The last closing price for HeartSciences was US$3.47. Over the last year, HeartSciences shares have traded in a share price range of US$ 2.36 to US$ 18.50.

HeartSciences currently has 980,321 shares outstanding. The market capitalization of HeartSciences is US$3.40 million. HeartSciences has a price to earnings ratio (PE ratio) of -0.51.

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company...

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Southlake, TX, July 29, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Southlake, TX, July 25, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Southlake, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.23	7.14285714286	3.22	3.5	3.1572	9956	3.35304283	CS
4	-0.3	-8	3.75	4.0799	3.1	18955	3.57983631	CS
12	0.46	15.3846153846	2.99	4.6902	2.5164	36971	3.48449807	CS
26	-0.25	-6.75675675676	3.7	5.2989	2.36	201428	4.02108744	CS
52	-8.55	-71.25	12	18.5	2.36	920537	10.72802135	CS
156	-371.55	-99.08	375	600	2.36	1703892	77.20390376	CS
260	-371.55	-99.08	375	600	2.36	1703892	77.20390376	CS

HSCS - Frequently Asked Questions (FAQ)

What is the current HeartSciences share price?

The current share price of HeartSciences is US$ 3.45

How many HeartSciences shares are in issue?

HeartSciences has 980,321 shares in issue

What is the market cap of HeartSciences?

The market capitalisation of HeartSciences is USD 3.4M

What is the 1 year trading range for HeartSciences share price?

HeartSciences has traded in the range of US$ 2.36 to US$ 18.50 during the past year

What is the PE ratio of HeartSciences?

The price to earnings ratio of HeartSciences is -0.51

What is the cash to sales ratio of HeartSciences?

The cash to sales ratio of HeartSciences is 177.84

What is the reporting currency for HeartSciences?

HeartSciences reports financial results in USD

What is the latest annual turnover for HeartSciences?

The latest annual turnover of HeartSciences is USD 19k

What is the latest annual profit for HeartSciences?

The latest annual profit of HeartSciences is USD -6.61M

What is the registered address of HeartSciences?

The registered address for HeartSciences is 550 RESERVE ST, SUITE 360, SOUTHLAKE, TEXAS, 76092

What is the HeartSciences website address?

The website address for HeartSciences is www.heartsciences.com

Which industry sector does HeartSciences operate in?

HeartSciences operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CDIOCardio Diagnostics Holdings Inc	US$ 0.8937 (44.64%)	1.35M
NEHCNew Era Helium Inc	US$ 3.82 (39.42%)	1.54M
ADSEADD TEC Energy PLC	US$ 19.03 (21.21%)	14.22k
NFXLDirexion Daily NFLX Bull 2X Shares	US$ 42.26 (19.89%)	174.22k
MKZRMackenzie Realty Capital Inc	US$ 2.48 (14.29%)	372
MYNAMynaric AG	US$ 0.5612 (-16.20%)	554.29k
INMInMed Pharmaceuticals Inc	US$ 4.30 (-15.02%)	39.03k
AGYSAgilysys Inc	US$ 112.00 (-11.02%)	9.31k
CJETChijet Motor Company Inc	US$ 1.88 (-10.48%)	34.29k
DWTXDogwood Therapeutics Inc	US$ 2.85 (-10.38%)	168.86k
TLTiShares 20 plus Year Treasury Bond	US$ 87.87 (-0.10%)	3.72M
GCTKGlucoTrack Inc	US$ 0.128 (4.40%)	3.3M
NVDANVIDIA Corporation	US$ 140.83 (0.00%)	2.84M
SOFISoFi Technologies Inc	US$ 17.88 (-0.11%)	2.2M
EWCZEuropean Wax Center Inc	US$ 6.87 (-0.07%)	2.06M